Dr. Charles Ide, Western Michigan University Gwen Frostic Professor of Biological Sciences and Director of the Great Lakes Environmental and Molecular Sciences Center, has been researching a deadly ...

Dublin, May 07, 2025 (GLOBE NEWSWIRE) -- The "Multiple System Atrophy (MSA) Market - A Global and Regional Analysis: Focus on Country and Regional Analysis - Analysis and Forecast, 2025-2035" report ...

The MarketWatch News Department was not involved in the creation of this content. The MSA Centers of Excellence (COE) initiative aims to establish a network of premier clinical centers, strategically ...

Multiple system atrophy (MSA) is a serious neurodegenerative disease with no available disease-altering therapies and no cure. Its natural history covers a 6 to 9 year course, during which the disease ...

MELBOURNE, Australia and SAN FRANCISCO, April 28, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing ...

Multiple system atrophy (MSA) is a rare neurological disorder. It causes nerve cells in parts of your brain to gradually decline. Over time, this damage affects your body’s involuntary processes.

WASHINGTON — Colleen Kellerman left the house only two times in the final six months of her life — once in September to shop for her granddaughter’s birthday and once in December. She had told all of ...

Toronto, ON, February 19, 2020/InsPress/ – MSA launches new website and introduces several new features to its flagship MSA Researcher Platforms covering the Canadian insurance industry. “We are ...

Long-time CEO of MSA Research Joel Baker will transition into the role of vice chairman as president Nevina Kishun steps into the role of chief executive officer, the insurance industry research firm ...